market research report : stem cell research marklet in india 2012
DESCRIPTION
For the complete report, get in touch with us at : [email protected] The stem cell research in India is in its nascent stage and is gradually on a growth path of acceptance by people. The market is still in a phase of conducting research to establish itself as one of the best therapies for the widely prevalent incurable lifestyle diseases. Awareness campaigns and doctors are playing a key role educating people and especially would-be parents about the benefits associated with preserving stem cells. The report begins with the introduction section which offers a brief insight of the concept of stem cell therapy and banking, the conventional sources of stem cells and the current and future therapeutic solutions for the most risky diseases. It then moves to the market overview section which provides an insight of the Indian stem cell therapy market, with highlight on the market size and growth. It also covers the market size and growth prospect of the stem cell banking market in India. In addition to these, the report gives a snapshot of the current and expected stem cell banking customers. An analysis of the drivers explains the factors for growth of the industry that include favourable regulatory environment, high patient population, stem cell application in drug development, rising consumer awareness, a rise in medical tourism and an increase in research and development expenditure to ensure stem cell therapy as a viable treatment for the numerous diseases. The key challenges include high cost of therapy, capital intensive market and high development costs of stem cell resulting in slow progress of the market. The next section of the report provides the progressive stages that the stem cell research is undergoing and the respective business prospect for each of the stages of business involved. The report then covers the key trends that are being observed in the stem cell research. Collaborations and partnerships are becoming a trend that is helping in healthy progress of the business, investments are pouring in from government, international organizations and pharmaceutical companies, serious efforts are being undertaken to raise awareness standards regarding stem cell therapy and the move is being popularized by stem cell banks by providing easy financing opportunities for banking stem cells. Significant developments have emerged wherein new sources of stem cells have been identified – dental stem cells and menstrual blood stem cells which have been discussed along with its benefits in comparison to cord blood stem cells. The competition section gives overview of stem cell banks and stem cell research organizations in the country. The report highlights the features of the major players operating in the market in detail. It includes elaborate profile of the major players in the market along with their financial analysis. Porters Five Forces Analysis has been incorporatedTRANSCRIPT
Insert Cover Image using Slide Master ViewDo not distort
Stem Cell Research IndiaStem Cell Research – India
July 2012
Executive Summary
Market
• The Stem Cell Therapy market in India was valued at INR x1 units in 20‐‐ which is expected to reach INR x2 units approximately by 20‐‐• The Stem Cell Banking Market was worth INR y1 units in 20‐‐ and is expected to reach INR y2units in 20‐‐
• India is projected to see a rise in number of stem cell bank and stem cell depositors in near
Drivers: Challenges:
• India is projected to see a rise in number of stem cell bank and stem cell depositors in near future
•Favorable Regulatory Environment•High Cost of Therapy
Drivers & Challenges
•High Patient Population•Application in Drug Development•Increasing Awareness•Growing Medical Tourism•Increasing Health Expenditure
•High Cost of Therapy• Capital intensive nature of research is decelerating the market
• ‘Development Costs’ of Stem Cell resulting in slow progress of the market
Trends
•Increasing Health Expenditure
•Increasing partnerships•Increasing investments
• Efforts to increase awareness in stem cell• Easy financing opportunities in stem cell banking
Competition
Major Players
Stem Cell Banks Company A, Company B, Company C, Company D, Company E, Company F
Organization A Organization B Organization C Organization D
STEM CELL RESEARCH MARKET IN INDIA 2012.PPT 2
Stem Cell Research OrganizationsOrganization A, Organization B, Organization C, Organization D, Organization E, Organization F, Organization G, Organization H
•Introduction•Market Overview•Drivers & Challenges•Value ChainM k t T d•Market Trends•Potential Stem Cell Sources•Competition•Competition Stem Cell Banks Research OrganizationsResearch Organizations
•Recent Developments•Strategic Recommendations
STEM CELL RESEARCH MARKET IN INDIA 2012.PPT 3
g•Appendix
Stem cell banking and therapeutic application are the two key area of concern which are bridged by stem cell research
Stem Cell can be the solution to a myriad of diseases like Parkinson's disease, amyotrophic lateral sclerosis, spinal cord injury, burns, heart disease, diabetes and arthritis and also for neurological problems like autism and cerebral
palsy and is also becoming an important tool for testing potential drug toxicity
• It is an emerging therapy wherein a damaged tissue • It is a concept of preserving the stem cells for specific future therapeutic uses
Stem Cell Therapy Stem Cell Banking
that cannot heal itself is repaired by the use of stem cell• Stem cells are the unspecialized blood cell that has the capacity to replicate and produce its own blood cells, platelets, red and white blood cells
• The “Cord Blood” is a rich source of stem cells and a
• The extraction of cord blood stem cells take about 10–15 minutes and is applicable to both normal and caesarean deliveries
• The cells can be cryo‐frozen and kept stored for decades in liquid nitrogen• The Cord Blood is a rich source of stem cells and a
critical input for such surgical treatmentsliquid nitrogen
• Cord blood is more like a ‘biological future health insurance’ for the newborn baby and its future offspring’s and siblings
•Use not restricted•No remuneration collected•Usage subject to availability
Public Banks
•For use of family only•Facility paid for by family•Availability guaranteed
Private Banks
STEM CELL RESEARCH MARKET IN INDIA 2012.PPT 4
The benefits of stem cell is manifold as the cell’s usage is not just restricted to the child but siblings or family members can use the cells if required, after a tissue matching is done
Stem cell therapy market is poised to grow at a very high rate due to increasing therapeutic applications
• The Stem Cell Therapy market in India was valued atINR x1 units in 20‐‐
Stem Cell Therapy Market – Overview Market Size and Growth
80
INR units
• The market is expected to reach INR x6 unitsapproximately by 20‐‐, growing at a CAGR of X% forthis time period
• The stem cell research is a key factor that propels thetherapeutic market 20
40
60 X% x6x5
x4x3
x2x1x0
therapeutic market
• Almost m stem cell transplants are carried out inIndia annually that is growing gradually
0
20
20‐‐e20‐‐e20‐‐e20‐‐e20‐‐e20‐‐20‐‐
Stem Cell Banking Market Overview Market Size and Growth
• The Stem Cell Banking Market was worth INR y1units in 20‐‐ and is expected to reach INR y6 units in20‐‐
h ll b k k d h b
Stem Cell Banking Market – Overview
8
10
INR units
y6
Market Size and Growth
• The stem cell banking market is expected to exhibit aCAGR of Y% between 20‐‐ and 20‐‐
• Stem cell banking that was unheard of a few yearsback but has become popular in the recent past as aless traumatic alternative to treat neurological 2
4
6
8Y% y5
y4y3
y2y1y0
STEM CELL RESEARCH MARKET IN INDIA 2012.PPT 5
less traumatic alternative to treat neurologicaldiseases and as guarantee for the entire familyagainst several other diseases
020‐‐e20‐‐e20‐‐e20‐‐e20‐‐e20‐‐20‐‐
Drivers & Challenges – Summary
iDrivers
Favorable Regulatory EnvironmentChallenges
High Patient Population
Application in Drug Development
High Cost of Therapy
Capital Intensive Market
Increasing Awareness
Growing Medical Tourism
High Development Cost
Increasing R&D Expenditure
STEM CELL RESEARCH MARKET IN INDIA 2012.PPT 6
Trends – Summary
Easy financing opportunities in stem cell banking Increasing Partnerships
Key Trends
Efforts to increase awareness in stem cell
Increasing Investments
STEM CELL RESEARCH MARKET IN INDIA 2012.PPT 7
Private: Foreign Company – Company A (1/3)
Company Information Offices and Centres – India
Corporate Address
Company A
Street A
City BCity B
State C
Tel No. +91 124 7239
Fax No +91 124 4734111
City B
P d t d S i
Fax No. +91 124 4734111
Website www.CompanyAcom
Year of Incorporation 2005
Key People
Products and Services
Category Products/Services
Stem cell banking Engages in collection, isolation and storage of cord blood stem cells
Head Office
Name Designation
Person A Chairman
Person B Managing Director
Person C CEO
STEM CELL RESEARCH MARKET IN INDIA 2012.PPT 8
Person C CEO
i i l S h K i
Private: Foreign Company – Company A (2/3)
Financial Snapshot Key Ratios
Particulars y‐o‐y change (2011‐10)
2011 2010 2009 2008
Profitability RatiosOperating Margin
Net Profit/LossTotal Income
INR units
‐20
INR units
250Net MarginProfit Before Tax MarginReturn on EquityReturn on Capital EmployedReturn on Working CapitalReturn on Assets
20
‐40
‐60
250
200
150
100
50
dR4c
R3b
R2
a
Return on Fixed Assets
Cost RatiosOperating costs (% of Sales)Administration costs (% of Sales)
Interest costs (% of Sales)Financial Summary
‐80
50
020‐‐20‐‐20‐‐20‐‐
R1
Interest costs (% of Sales)
Liquidity RatiosCurrent RatioCash Ratio
Leverage RatiosDebt to Equity Ratio
b i l i
• The company incurred a net loss of INR d units in FY 20‐‐, as compared to net loss of INR c units in FY 20‐‐
• The company reported total income of INR R4 units in FY 20‐‐, registering an increase of m% over FY 20‐‐
Debt to Capital RatioInterest Coverage Ratio
Efficiency RatiosFixed Asset TurnoverAsset TurnoverCurrent Asset Turnover
• The company earned an operating margin of f% in FY 20‐‐, an increase of g percentage points over FY 20‐‐
• The company reported debt to equity ratio of d in FY 20‐‐, a decrease of h% over FY 20‐‐
STEM CELL RESEARCH MARKET IN INDIA 2012.PPT 9
Working Capital TurnoverCapital Employed Turnover
Improved Decline
Private: Foreign Company – Company A (3/3)
Business Highlights
Description News
Overview • It was formed as a joint venture between Company A and Company B
Stem Cell Banking • It provides collection facility from all major cities in India
Recognitions• The company was awarded the most prestigious American Association of Blood Banks (AABB) Accreditation
STEM CELL RESEARCH MARKET IN INDIA 2012.PPT 10
Appendix
Ratio Calculations
Operating Margin (Operating Income/Revenues)*100
Ratio Calculations
Current RatioCurrent Assets / Current Liabilities
Net Margin (Net Profit / Revenues) *100
Profit Before Tax Margin (Income Before Tax / Revenues *100
(N I / Sh h ld
Cash Ratio{(Cash & Bank Balance + Marketable Securities) / Current Liabilities)}
Debt to Equity Total Liabilities / Shareholders E it
Return on Equity (ROE) (Net Income / Shareholders Equity)*100
Return on Capital (ROCE) EBIT / (Total Assets – Current Liabilities)*100
(N I / W ki C i l)
q yEquity
Debt to Capital Ratio{Total Debt / (Shareholders Equity + Total Debt)}
Interest Coverage Ratio EBIT / Interest Expense
Return on Working Capital (Net Income / Working Capital) *100
Return on Assets (Net Income / Total Assets)*100
Return on Fixed Assets (Net Income / Fixed Assets) *100
Fixed Asset Turnover Sales / Fixed Assets
Asset Turnover Sales / Total Assets
Operating Costs (% of Sales) (Operating Expenses / Sales) *100
Administration Costs (% of Sales)
(Administrative Expenses / Sales) *100
Current Asset Turnover Sales / Current Assets
Working Capital Turnover Sales / Working Capital
/
STEM CELL RESEARCH MARKET IN INDIA 2012.PPT 11
Interest Costs (% of Sales) (Interest Expenses / Sales) *100 Capital Employed Turnover Sales / Shareholders Equity
Thank you for the attentionThe Stem Cell Research Market – India report is part of Research on India’s Healthcare Series.For more detailed information or customized research requirements please contact:
Phone: +91 33 4064 6214Phone: 91 33 4064 6214E‐Mail: [email protected]
Follow us on:
About NetscribesNetscribes is a knowledge‐consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of investment & g g f g p y p p fbusiness research, business & corporate intelligence, content‐management services, and knowledge‐software services. At its core lies a true value proposition that draws upon a vast knowledge base. Netscribes is a one‐stop shop designed to fulfil clients’ profitability and growth objectives.
Disclaimer: This report is published for general information only Although high standards have been used in the preparation “Netscribes” is
STEM CELL RESEARCH MARKET IN INDIA 2012.PPT 12
Disclaimer: This report is published for general information only. Although high standards have been used in the preparation, Netscribes is not responsible for any loss or damage arising from use of this document. This document is the sole property of Netscribes and prior permission is required for guidelines on reproduction.